Financial Statements >
Notes >
Notes on the consolidated statement of income >
13. Earnings per share
- 3. Special items
- 4. Sales
- 5. Cost of sales
- 6. Cost of materials
- 7. Personnel expenses
- 8. Selling, general and administrative expenses
- 9. Investment gain
- 10. Net interest
- 11. Other financial result
- 12. Taxes
- 13. Earnings per share
13. Earnings per share
The following table shows the earnings per share including and excluding the dilutive effect from stock options issued:
2012 | 2011 | |
---|---|---|
Numerators, € in millions | ||
Net income attributable to shareholders of Fresenius SE & Co. KGaA |
926 | 690 |
less effect from dilution due to Fresenius Medical Care shares | 2 | 3 |
Income available to all ordinary shares | 924 | 687 |
Denominators in number of shares | ||
Weighted-average number of ordinary shares outstanding | 172,977,633 | 162,797,197 |
Potentially dilutive ordinary shares | 1,547,170 | 1,522,534 |
Weighted-average number of ordinary shares outstanding assuming dilution | 174,524,803 | 164,319,731 |
Basic earnings per ordinary share in € | 5.35 | 4.24 |
Fully diluted earnings per ordinary share in € | 5.29 | 4.18 |
Back to:
12. Taxes
12. Taxes
Continue reading:
14. Cash and cash equivalents
14. Cash and cash equivalents